AR and prostate carcinoma: Moreover, using prostate cancer cells with different AR and GR status, we demonstrated clearly that CpdA could exert its cytostatic effect via both receptors which correlated with CpdA's dual GR/AR ligand properties shown in our earlier studies [35].